» Articles » PMID: 26853617

The Use of Magnetic Nanoparticles in Cancer Theranostics: Toward Handheld Diagnostic Devices

Overview
Journal Biotechnol Adv
Date 2016 Feb 9
PMID 26853617
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Magnetic nanoparticles are frequently used in a wide range of biomedical applications. In the first part of this review the most commonly used preparation and surface coating approaches of MNPs are briefly summarized including multifunctional hybrid particles. The second part gives a detailed overview of the use of MNPs in "traditional" biomedical applications related to cancer theranostics, like magnetic resonance imaging, drug delivery, hyperthermia and also their applicability in the next generation of point of care devices based on micro nuclear magnetic resonance and surface enhanced Raman spectroscopic detection technology that all can be routinely applied in everyday clinical practice.

Citing Articles

Smart nanoparticles for cancer therapy.

Sun L, Liu H, Ye Y, Lei Y, Islam R, Tan S Signal Transduct Target Ther. 2023; 8(1):418.

PMID: 37919282 PMC: 10622502. DOI: 10.1038/s41392-023-01642-x.


Radiosensitizing Effect of Dextran-Coated Iron Oxide Nanoparticles on Malignant Glioma Cells.

Tran N, Ryzhov V, Volnitskiy A, Amerkanov D, Pack F, Golubev A Int J Mol Sci. 2023; 24(20).

PMID: 37894830 PMC: 10606998. DOI: 10.3390/ijms242015150.


Emergence of Raman Spectroscopy as a Probing Tool for Theranostics.

Singh R, Yadav V, Dhillon A, Sharma A, Ahuja T, Siddhanta S Nanotheranostics. 2023; 7(3):216-235.

PMID: 37064614 PMC: 10093420. DOI: 10.7150/ntno.81936.


Nanotechnology-based diagnostic methods for coronavirus: From nucleic acid extraction to amplification.

Huang X, Fu R, Qiao S, Zhang J, Xianyu Y Biosens Bioelectron X. 2022; 13:100289.

PMID: 36530849 PMC: 9733970. DOI: 10.1016/j.biosx.2022.100289.


Advanced Magnetic Resonance Imaging (MRI) Techniques: Technical Principles and Applications in Nanomedicine.

Bruno F, Granata V, Bellisari F, Sgalambro F, Tommasino E, Palumbo P Cancers (Basel). 2022; 14(7).

PMID: 35406399 PMC: 8997011. DOI: 10.3390/cancers14071626.